|Podcasts|January 23, 2020
Episode 48: 2020 Industry Outlook
Author(s)Christen Harm, Elaine Quilici
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
Advertisement
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
5